Placeholder Banner

BIO Applauds Advancement of Senate Biomedical Innovation Legislation

March 9, 2016

Washington, D.C. (March 9, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative:

“BIO applauds today’s bipartisan votes by the Senate HELP Committee to advance legislation as part of the Senate biomedical innovation initiative. In particular, BIO applauds the Committee’s passage of The Advancing Hope Act of 2015, reauthorizing the Pediatric Rare Disease Priority Review Voucher Program, which provides an important incentive for companies developing treatments for rare pediatric diseases. We were also pleased that the Committee passed legislation to add the Zika virus to the Tropical Disease Priority Review Voucher program.

“BIO was very encouraged that the Committee passed the Medical Countermeasures Innovation Act of 2015, addressing a number of contracting and regulatory challenges and incentivizing further research and development of critical medical countermeasures products.

“BIO and our members have been engaged throughout this bipartisan process, and we look forward to working with members of the Committee on common sense reforms that will improve the entire ecosystem of innovation which patients rely upon to deliver new treatments. We thank Chairman Alexander, Ranking Member Murray and all members of the Committee for their commitment to this important work.”


Upcoming BIO Events 

BIO International Convention
June 6-9, 2016
San Francisco, Calif.


13th Annual BIO Asia International Conference
March 15-16, 2016
Tokyo, Japan

BIO-Europe Spring
April 4-6, 2016
Stockholm, Sweden


Discover More
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
Washington, D.C. (July 29, 2020) – The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Board leadership. Sylvia Wulf, CEO of AquaBounty Technologies, Inc., and Brian…